The burgeoning landscape of novel treatments for metabolic management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a alike https://ammaroouy250726.thebindingwiki.com/8724511/retatrutide_vs_tirzepatide_a_comparative_analysis